Provided by Tiger Fintech (Singapore) Pte. Ltd.

AxoGen

9.73
+0.44004.74%
Post-market: 9.730.00000.00%16:12 EDT
Volume:890.12K
Turnover:8.62M
Market Cap:443.14M
PE:-60.79
High:9.93
Open:9.45
Low:9.39
Close:9.29
Loading ...

AxoGen Q1 Adjusted Ebitda USD 2.9 Million VS. Ibes Estimate USD 3.95 Million

THOMSON REUTERS
·
08 May

AxoGen Inc - Expects to Be Net Cash Flow Positive for Full Year

THOMSON REUTERS
·
08 May

AxoGen Announces Chief Financial Officer Transition

THOMSON REUTERS
·
08 May

AxoGen Inc - Lindsey Hartley to Succeed Nir Naor as CFO

THOMSON REUTERS
·
08 May

AxoGen Inc - Appoints Lindsey Hartley as CFO Effective May 12

THOMSON REUTERS
·
08 May

Press Release: Axogen Announces Chief Financial Officer Transition

Dow Jones
·
08 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025

GlobeNewswire
·
24 Apr

AxoGen Expects Minimal Impact from New Tariffs

TIPRANKS
·
07 Apr

AxoGen Inc - Anticipates Minimal Impact From New US Tariffs - SEC Filing

THOMSON REUTERS
·
07 Apr

AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy

TIPRANKS
·
24 Mar

AxoGen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
24 Mar

Press Release: Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
24 Mar

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75%

Simply Wall St.
·
17 Mar

Lake Street Initiates Axogen at Buy With $30 Price Target

MT Newswires Live
·
17 Mar

Axogen Price Target Maintained With a $26.00/Share by Citizens Capital Markets

Dow Jones
·
05 Mar

AxoGen’s Strategic Market Positioning and Anticipated BLA Approval Drive Buy Rating

TIPRANKS
·
05 Mar

AxoGen Reports Strong Growth and Positive Outlook

TIPRANKS
·
28 Feb

Axogen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
27 Feb

Axogen Is Maintained at Market Outperform by Citizens Capital Markets

Dow Jones
·
26 Feb